Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

March 26, 2019

Study Completion Date

March 26, 2019

Conditions
Dermatitis, Atopic
Interventions
DRUG

PF-04965842 100 mg

PF-04965842 100 mg, administered as two tablets to be taken orally once daily for 12 weeks

DRUG

PF-04965842 200 mg

PF-04965842 200 mg, administered as two tablets to be taken orally once daily for 12 weeks

DRUG

Placebo

Placebo, administered as two tablets to be taken orally once daily for 12 weeks

Trial Locations (88)

2035

Australian Clinical Research Network (ACRN), Maroubra

Spectrum Medical Imaging, Maroubra

3002

Melbourne Radiology Clinic, East Melbourne

Sinclair Dermatology, East Melbourne

3052

The Royal Children's Hospital, Parkville

3053

Skin and Cancer Foundation Inc, Carlton

3121

Bridge Road Imaging, Richmond

3124

Emeritus Research, Camberwell

3529

CRU Hungary Ltd., Miskolc

4032

Debreceni Egyetem Klinikai Kozpont Borgyogyaszati Klinika, Debrecen

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

4122

Queensland X-Ray, Upper Mount Gravatt

6000

Bács-Kiskun Megyei Kórház, Bőr-és nemibeteg Szakrendelés, Kecskemét

Bacs-Kiskun Megyei Korhaz Kozponti Radiologiai Osztaly, Kecskemét

7632

Pecsi Tudomanyegyetem Klinikai Kozpont, Bor-,Nemikortani es Onkodermatologiai Klinika, Pécs

Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs

10117

Charité - Universitaetsmedizin Berlin, CCM, Berlin

10789

ISA - Interdisciplinary Study Association GmbH, Berlin

11000

Sanatorium profesora Arenbergera, Prague

19055

Klinische Forschung Schwerin GmbH, Schwerin

23502

Virginia Clinical Research, Inc., Norfolk

23538

Universitaetsklinikum Schleswig-Holstein/Campus Luebeck, Lübeck

24105

Universitaetsklinikum Schleswig-Holstein, Campus Kiel, Kiel

28401

Kozni ambulance Kutna Hora, s.r.o., Kutná Hora

29425

Medical University of South Carolina Investigational Drug Services, Charleston

MUSC SCTR Research Nexus Clinic and Laboratory, Charleston

31406

Meridian Clinical Research, LLC, Savannah

33134

Florida Academic Centers Research and Education, LLC, Coral Gables

33624

Forward Clinical Trials, Inc., Tampa

33770

Olympian Clinical Research, Largo

35209

Clinical Research Center of Alabama, LLC, Birmingham

40113

Krajska zdravotni a.s.,Masarykova nemocnice o.z., Ústí nad Labem

Lekarna Masarykovy nemocnice v Usti nad Labem, o.z., Ústí nad Labem

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Dawes Fretzin Dermatology Group, LLC, Indianapolis

48084

Somerset Skin Centre, Troy

48149

Universitätsklinikum Münster, Münster

48202

Henry Ford Medical Center, New Center One, Detroit

48455

Fachklinik Bad Bentheim, Bad Bentheim

60077

NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie

64506

MediSearch Clinical Trials, Saint Joseph

70852

Fakultni Nemocnice Ostrava, Kozni oddeleni, Ostrava - Poruba

73112

Lynn Health Science Institute, Oklahoma City

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

76011

Arlington Research Center, Inc., Arlington

77030

The University of Texas Health Science Center Houston, Houston

78218

Texas Dermatology and Laser Specialists, San Antonio

80337

Ludwig-Maximilians-University Munich, Munich

90404

Clinical Science Institute, Santa Monica

91054

Universitätsklinikum Erlangen, Hautklinik, Erlangen

92024

California Dermatology & Clinical Research Institute, Encinitas

92123

Rady Children's Hospital - San Diego/University of California, San Diego, San Diego

TCR Medical Corporation, San Diego

97239

Oregon Health & Science University, Portland

98405

MultiCare Allenmore Hospital, Tacoma

MultiCare Institute for Research and Innovation, Tacoma

Pace Dermatology Associates, Tacoma

98499

Pace Dermatology Associates, Lakewood

02111

Tufts Medical Center, Boston

T2G 1B1

Kirk Barber Research, Calgary

T3A 2N1

Institute for Skin Advancement, Calgary

V3R 6A7

Dr. Chih-ho Hong Medical Inc, Surrey

V5Z 4E8

University of British Columbia Department of Dermatology and Skin Science, Vancouver

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L3P 1X2

Lynderm Research Inc, Markham

K9J 5K2

SKiN Centre for Dermatology, Peterborough

L4B 1A5

The Centre for Dermatology, Richmond Hill

L4C 9M7

York Dermatology Center, Richmond Hill

M4W 2N2

Research Toronto, Toronto

H2K 4L5

Innovaderm Research Inc., Montreal

J1L 0H8

Diex Research Sherbrooke Inc., Sherbrooke

284 01

Lekarna Na Vaclavskem namesti, Kutná Hora

708 52

Lekarna Fakultni Nemocnice Ostrava, Ostrava - Poruba

120 00

Lekarna U sv. Ignace, Prague

01307

Universitaetsklinikum Carl Gustav Carus der Technischen Universitaet Dresden, Dresden

40-123

MULTIKLINIKA Salute Sp. z o.o., Katowice

40-282

Silmedic Sp. z o.o., Oddzial w Katowicach, Katowice

40-611

Centrum Medyczne Angelius Provita, Katowice

40-648

Pro Familia Altera Sp. z o.o., Katowice

90-265

"NZOZ DERMED Centrum Medyczne Sp. z o.o. - Oddzial w Lodzi", Lodz

90-436

Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak, Lodz

27-400

Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski

04-141

Wojskowy Instytut Medyczny, Klinika Dermatologiczna, Warsaw

PL6 8DH

Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth

NW3 2QG

Royal Free London NHS Foundation Trust, London

S5 7AU

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

S10 2TH

Sheffield Children's Hospital NHS Foundation Trust, Sheffield

DY1 2HQ

The Dudley Group NHS Foundation Trust, Dudley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03349060 - Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter